The Canadian Journal of Neurological Sciences This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Pac-Man ghost sign in bilateral hypertrophic olivary degeneration
Can J Neurol Sci. 2023 May 19:1-6. doi: 10.1017/cjn.2023.56. Online ahead of print.NO ABSTRACTPMID:37203792 | DOI:10.1017/cjn.2023.56 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 19, 2023 Category: Neurology Authors: Camila Abreu-Silveira Fabiano Reis Egberto R Barbosa Laura Silveira-Moriyama Source Type: research

Distinguishing tics secondary to juvenile Huntington's disease from a primary tic disorder
Can J Neurol Sci. 2023 May 19:1-7. doi: 10.1017/cjn.2023.69. Online ahead of print.NO ABSTRACTPMID:37203796 | DOI:10.1017/cjn.2023.69 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 19, 2023 Category: Neurology Authors: Jason L Chan Justyna R Sarna Source Type: research

Split phenomenon of fasciculation between antagonistic muscles in amyotrophic lateral sclerosis: an ultrasound study
Can J Neurol Sci. 2023 May 15:1-22. doi: 10.1017/cjn.2023.62. Online ahead of print.NO ABSTRACTPMID:37183728 | DOI:10.1017/cjn.2023.62 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 15, 2023 Category: Neurology Authors: Nan Hu Yi Li Jingwen Liu Liying Cui Mingsheng Liu Source Type: research

Beyond Diagnose-and-Adios: Musings of a Retired Stroke Neurologist
Can J Neurol Sci. 2023 May;50(3):462-463. doi: 10.1017/cjn.2022.45. Epub 2022 Apr 25.NO ABSTRACTPMID:37185329 | DOI:10.1017/cjn.2022.45 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 15, 2023 Category: Neurology Authors: Stephen J Phillips Source Type: research

Engaging with Indigenous Communities in Brain Science: Not Only the What, But the Way
Can J Neurol Sci. 2023 May;50(3):479-480. doi: 10.1017/cjn.2022.68.NO ABSTRACTPMID:37185330 | DOI:10.1017/cjn.2022.68 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 15, 2023 Category: Neurology Authors: Louise Harding Malcolm King Sharon Jinkerson-Brass Bryce Mercredi Cornelia Wieman Judy Illes Source Type: research

Cerebral air embolism following catheter ablation for atrial fibrillation
Can J Neurol Sci. 2023 May 9:1-5. doi: 10.1017/cjn.2023.55. Online ahead of print.NO ABSTRACTPMID:37157857 | DOI:10.1017/cjn.2023.55 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 9, 2023 Category: Neurology Authors: Juan Pablo Millan Sandoval Gabrielle Dufort Laurent Letourneau-Guillon Moishe Liberman C éline Odier Source Type: research

Ischemic stroke due to carotid artery stenosis in a patient with Hughes Syndrome
Can J Neurol Sci. 2023 May 9:1-5. doi: 10.1017/cjn.2023.57. Online ahead of print.NO ABSTRACTPMID:37158219 | DOI:10.1017/cjn.2023.57 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 9, 2023 Category: Neurology Authors: Yanli Du Siyang Zheng Hui Qi Zongli Han Source Type: research

Patient Safety in Canadian Epilepsy Monitoring Units: A Survey of Current Practices
Can J Neurol Sci. 2023 May 10:1-25. doi: 10.1017/cjn.2023.58. Online ahead of print.NO ABSTRACTPMID:37160380 | DOI:10.1017/cjn.2023.58 (Source: The Canadian Journal of Neurological Sciences)
Source: The Canadian Journal of Neurological Sciences - May 9, 2023 Category: Neurology Authors: Emmanuelle Nguyen Jimmy Li Dang Khoa Nguyen Elie Bou Assi Source Type: research

Placebo Effects and Neuromodulation: Ethical Considerations and Recommendations
Can J Neurol Sci. 2023 Jun;50(s1):s34-s41. doi: 10.1017/cjn.2023.24. Epub 2023 May 10.ABSTRACTPlacebo-controlled trials are the gold standard of evaluating treatment efficacy in clinical research. Neuromodulation is emerging as an important treatment pathway for many neuropsychiatric conditions, and placebo control arms of these trials require careful design with unique considerations (e.g., sham devices that mimic active stimulation, blinding effectiveness). Inherent to placebo-controlled trials are ethical concerns, such as deception, and potential harm of not receiving the active treatment. In this article, we outline i...
Source: The Canadian Journal of Neurological Sciences - May 9, 2023 Category: Neurology Authors: Adriano Mollica Rachel Greben Marieve Cyr Jay A Olson Matthew J Burke Source Type: research